CDEK
← All organizations
Enzyvant Therapeutics GmbH

Enzyvant Therapeutics GmbH

For profitWebsite ↗

Also known as: Enzyvant Therapeutics GmbH | Enzyvant Therapeutics GmBH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

Last known activity

Dec 1, 2010

Acquired by Sumitomo Dainippon on Sep 6, 2019

Timeline

2010s

  1. Jan 1, 2016

    Enzyvant Therapeutics GmbH— Founded

  2. Sep 6, 2019

    Sumitomo Dainippon— Acquired By

Drugs by trial phase (8 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Recent trials (2)

Details

Founded
Cambridge, MA, US Jan 1, 2016
Last known activity
Dec 1, 2010